This report contains market size and forecasts of Natural Killer (NK) Cell Therapeutics in Global, including the following market information:
Global Natural Killer (NK) Cell Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Natural Killer (NK) Cell Therapeutics market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Publisher has surveyed the Natural Killer (NK) Cell Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Natural Killer (NK) Cell Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Natural Killer (NK) Cell Therapeutics Market Segment Percentages, By Type, 2020 (%)
Mogamulizumab
Lorvotuzumab Mertansine
Others
China Natural Killer (NK) Cell Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Natural Killer (NK) Cell Therapeutics Market Segment Percentages, By Application, 2020 (%)
Cancer
Cardiovascular Diseases
Others
Global Natural Killer (NK) Cell Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Natural Killer (NK) Cell Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Natural Killer (NK) Cell Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Natural Killer (NK) Cell Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Chipscreen Biosciences
Affimed NV
Altor BioScience
Innate Pharma
Takeda
Sorrento Therapeutics
NantKwest
Bristol-Myers Squibb
NKT
Henry Ford Health Services
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Natural Killer (NK) Cell Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Natural Killer (NK) Cell Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Natural Killer (NK) Cell Therapeutics Overall Market Size
2.1 Global Natural Killer (NK) Cell Therapeutics Market Size: 2021 VS 2027
2.2 Global Natural Killer (NK) Cell Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Natural Killer (NK) Cell Therapeutics Players in Global Market
3.2 Top Global Natural Killer (NK) Cell Therapeutics Companies Ranked by Revenue
3.3 Global Natural Killer (NK) Cell Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Natural Killer (NK) Cell Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Natural Killer (NK) Cell Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Natural Killer (NK) Cell Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Natural Killer (NK) Cell Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Natural Killer (NK) Cell Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Natural Killer (NK) Cell Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Mogamulizumab
4.1.3 Lorvotuzumab Mertansine
4.1.4 Others
4.2 By Type - Global Natural Killer (NK) Cell Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Natural Killer (NK) Cell Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global Natural Killer (NK) Cell Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Natural Killer (NK) Cell Therapeutics Market Size, 2021 & 2027
5.1.2 Cancer
5.1.3 Cardiovascular Diseases
5.1.4 Others
5.2 By Application - Global Natural Killer (NK) Cell Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Natural Killer (NK) Cell Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global Natural Killer (NK) Cell Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Natural Killer (NK) Cell Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Natural Killer (NK) Cell Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Natural Killer (NK) Cell Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global Natural Killer (NK) Cell Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Natural Killer (NK) Cell Therapeutics Revenue, 2016-2027
6.3.2 US Natural Killer (NK) Cell Therapeutics Market Size, 2016-2027
6.3.3 Canada Natural Killer (NK) Cell Therapeutics Market Size, 2016-2027
6.3.4 Mexico Natural Killer (NK) Cell Therapeutics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Natural Killer (NK) Cell Therapeutics Revenue, 2016-2027
6.4.2 Germany Natural Killer (NK) Cell Therapeutics Market Size, 2016-2027
6.4.3 France Natural Killer (NK) Cell Therapeutics Market Size, 2016-2027
6.4.4 U.K. Natural Killer (NK) Cell Therapeutics Market Size, 2016-2027
6.4.5 Italy Natural Killer (NK) Cell Therapeutics Market Size, 2016-2027
6.4.6 Russia Natural Killer (NK) Cell Therapeutics Market Size, 2016-2027
6.4.7 Nordic Countries Natural Killer (NK) Cell Therapeutics Market Size, 2016-2027
6.4.8 Benelux Natural Killer (NK) Cell Therapeutics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Natural Killer (NK) Cell Therapeutics Revenue, 2016-2027
6.5.2 China Natural Killer (NK) Cell Therapeutics Market Size, 2016-2027
6.5.3 Japan Natural Killer (NK) Cell Therapeutics Market Size, 2016-2027
6.5.4 South Korea Natural Killer (NK) Cell Therapeutics Market Size, 2016-2027
6.5.5 Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size, 2016-2027
6.5.6 India Natural Killer (NK) Cell Therapeutics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Natural Killer (NK) Cell Therapeutics Revenue, 2016-2027
6.6.2 Brazil Natural Killer (NK) Cell Therapeutics Market Size, 2016-2027
6.6.3 Argentina Natural Killer (NK) Cell Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue, 2016-2027
6.7.2 Turkey Natural Killer (NK) Cell Therapeutics Market Size, 2016-2027
6.7.3 Israel Natural Killer (NK) Cell Therapeutics Market Size, 2016-2027
6.7.4 Saudi Arabia Natural Killer (NK) Cell Therapeutics Market Size, 2016-2027
6.7.5 UAE Natural Killer (NK) Cell Therapeutics Market Size, 2016-2027
7 Players Profiles
7.1 Chipscreen Biosciences
7.1.1 Chipscreen Biosciences Corporate Summary
7.1.2 Chipscreen Biosciences Business Overview
7.1.3 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.1.4 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue in Global (2016-2021)
7.1.5 Chipscreen Biosciences Key News
7.2 Affimed NV
7.2.1 Affimed NV Corporate Summary
7.2.2 Affimed NV Business Overview
7.2.3 Affimed NV Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.2.4 Affimed NV Natural Killer (NK) Cell Therapeutics Revenue in Global (2016-2021)
7.2.5 Affimed NV Key News
7.3 Altor BioScience
7.3.1 Altor BioScience Corporate Summary
7.3.2 Altor BioScience Business Overview
7.3.3 Altor BioScience Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.3.4 Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue in Global (2016-2021)
7.3.5 Altor BioScience Key News
7.4 Innate Pharma
7.4.1 Innate Pharma Corporate Summary
7.4.2 Innate Pharma Business Overview
7.4.3 Innate Pharma Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.4.4 Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue in Global (2016-2021)
7.4.5 Innate Pharma Key News
7.5 Takeda
7.5.1 Takeda Corporate Summary
7.5.2 Takeda Business Overview
7.5.3 Takeda Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.5.4 Takeda Natural Killer (NK) Cell Therapeutics Revenue in Global (2016-2021)
7.5.5 Takeda Key News
7.6 Sorrento Therapeutics
7.6.1 Sorrento Therapeutics Corporate Summary
7.6.2 Sorrento Therapeutics Business Overview
7.6.3 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.6.4 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue in Global (2016-2021)
7.6.5 Sorrento Therapeutics Key News
7.7 NantKwest
7.7.1 NantKwest Corporate Summary
7.7.2 NantKwest Business Overview
7.7.3 NantKwest Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.4.4 NantKwest Natural Killer (NK) Cell Therapeutics Revenue in Global (2016-2021)
7.7.5 NantKwest Key News
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Corporate Summary
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.8.4 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue in Global (2016-2021)
7.8.5 Bristol-Myers Squibb Key News
7.9 NKT
7.9.1 NKT Corporate Summary
7.9.2 NKT Business Overview
7.9.3 NKT Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.9.4 NKT Natural Killer (NK) Cell Therapeutics Revenue in Global (2016-2021)
7.9.5 NKT Key News
7.10 Henry Ford Health Services
7.10.1 Henry Ford Health Services Corporate Summary
7.10.2 Henry Ford Health Services Business Overview
7.10.3 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.10.4 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue in Global (2016-2021)
7.10.5 Henry Ford Health Services Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Natural Killer (NK) Cell Therapeutics Market Opportunities & Trends in Global Market
Table 2. Natural Killer (NK) Cell Therapeutics Market Drivers in Global Market
Table 3. Natural Killer (NK) Cell Therapeutics Market Restraints in Global Market
Table 4. Key Players of Natural Killer (NK) Cell Therapeutics in Global Market
Table 5. Top Natural Killer (NK) Cell Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Natural Killer (NK) Cell Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Natural Killer (NK) Cell Therapeutics Product Type
Table 9. List of Global Tier 1 Natural Killer (NK) Cell Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Natural Killer (NK) Cell Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Natural Killer (NK) Cell Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Natural Killer (NK) Cell Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Natural Killer (NK) Cell Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Natural Killer (NK) Cell Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2022-2027
Table 30. Chipscreen Biosciences Corporate Summary
Table 31. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Product Offerings
Table 32. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), (2016-2021)
Table 33. Affimed NV Corporate Summary
Table 34. Affimed NV Natural Killer (NK) Cell Therapeutics Product Offerings
Table 35. Affimed NV Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), (2016-2021)
Table 36. Altor BioScience Corporate Summary
Table 37. Altor BioScience Natural Killer (NK) Cell Therapeutics Product Offerings
Table 38. Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), (2016-2021)
Table 39. Innate Pharma Corporate Summary
Table 40. Innate Pharma Natural Killer (NK) Cell Therapeutics Product Offerings
Table 41. Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), (2016-2021)
Table 42. Takeda Corporate Summary
Table 43. Takeda Natural Killer (NK) Cell Therapeutics Product Offerings
Table 44. Takeda Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), (2016-2021)
Table 45. Sorrento Therapeutics Corporate Summary
Table 46. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Product Offerings
Table 47. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), (2016-2021)
Table 48. NantKwest Corporate Summary
Table 49. NantKwest Natural Killer (NK) Cell Therapeutics Product Offerings
Table 50. NantKwest Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), (2016-2021)
Table 51. Bristol-Myers Squibb Corporate Summary
Table 52. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Product Offerings
Table 53. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), (2016-2021)
Table 54. NKT Corporate Summary
Table 55. NKT Natural Killer (NK) Cell Therapeutics Product Offerings
Table 56. NKT Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), (2016-2021)
Table 57. Henry Ford Health Services Corporate Summary
Table 58. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Product Offerings
Table 59. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Natural Killer (NK) Cell Therapeutics Segment by Type
Figure 2. Natural Killer (NK) Cell Therapeutics Segment by Application
Figure 3. Global Natural Killer (NK) Cell Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Natural Killer (NK) Cell Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Natural Killer (NK) Cell Therapeutics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Natural Killer (NK) Cell Therapeutics Revenue in 2020
Figure 8. By Type - Global Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2016-2027
Figure 9. By Application - Global Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2016-2027
Figure 10. By Region - Global Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2016-2027
Figure 11. By Country - North America Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2016-2027
Figure 12. US Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2016-2027
Figure 16. Germany Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 17. France Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2016-2027
Figure 24. China Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 28. India Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2016-2027
Figure 30. Brazil Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2016-2027
Figure 33. Turkey Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 37. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Affimed NV Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Takeda Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. NantKwest Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. NKT Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Chipscreen Biosciences
Affimed NV
Altor BioScience
Innate Pharma
Takeda
Sorrento Therapeutics
NantKwest
Bristol-Myers Squibb
NKT
Henry Ford Health Services
+16467917070US (Toll Free)
